What is Apothecus Pharmaceutical?
Apothecus Pharmaceutical operates within the health care products sector, focusing on providing a safe and confidential online shop for purchasing spermicides, including foam, film, and other related items. Their product line emphasizes hormone-free, safe, and effective solutions, aiming for customer satisfaction. A key offering is the VCF Vaginal Contraceptive Film, designed for rapid dissolution and effective protection, alongside VCF Contraceptive Gel, which comes in pre-filled applicators for convenient use against unwanted pregnancy. The company's strategic investments suggest a focus on scaling its direct-to-consumer health offerings and expanding its market reach.
How much funding has Apothecus Pharmaceutical raised?
Apothecus Pharmaceutical has raised a total of $465K across 2 funding rounds:
Debt
$150K
Debt
$315K
Debt (2020): $150K with participation from PPP
Debt (2021): $315K led by PPP
Key Investors in Apothecus Pharmaceutical
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Apothecus Pharmaceutical?
With its large-scale late-stage funding context, Apothecus Pharmaceutical is positioned for significant expansion and market penetration. The recent major strategic investment indicates a strong vote of confidence from its backers, likely enabling the company to enhance its product development, broaden its distribution channels, and potentially explore new therapeutic areas or product lines within reproductive health. Future growth will likely involve leveraging this capital to solidify its market position and further innovate in the accessible health care product space.
See full Apothecus Pharmaceutical company page
